drugset / Trial / NCT02253407

Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children

NCT02253407

Phase 4 Completed 341 enrolled Serum Institute of India Pvt. Ltd. PATH · collab
RandomizedParallel-groupSingle-blindPrevention

Summary

This is a study planned to determine and compare immunogenicity and reactogenicity of MMR vaccine of SIIL delivered either with disposable-Syringe Jet Injector (DSJI) or disposable-syringe needle in total 340 Indian infants aged 15 to 18 months.

Timeline

Start
2014-09
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject MMR vaccine Vaccine 0.5 ml Subcutaneous